Business
Xenon to Report Q1 2026 Financial Results on May 7, 2026
VANCOUVER, British Columbia and BOSTON, MA, April 30, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced it will report its first quarter 2026 financial results and provide a business update after the close of U.S. financial markets on Thursday, May 7, 2026. Company Presentation Details: Date:
About this update from Xenon Pharmaceuticals Inc.
[{"type":"image","alt":"Xenon Pharmaceuticals Inc.","displaySize":"","headline":null,"caption":"Xenon Pharmaceuticals Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":80,"url":"https://media.zenfs.com/en/globenewswire.com/512e4110e9e95e88ef2c02e7ad2efa3b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s7o.0OXnOJy5uOTuo0NkvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzNA--/https://media.zenfs.com/en/globenewswire.com/512e4110e9e95e88ef2c02e7ad2efa3b","width":250,"height":80}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia and BOSTON, MA, April 30, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced it will report its first quarter 2026 financial results and provide a business update after the close of U.S. financial markets on Thursday, May 7, 2026.","length":464,"tagName":"p"},{"type":"text","content":"Company Presentation Details:","length":29,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"Thursday, May 7, 2026","length":21,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"4:30pm ET (1:30pm PT)","length":21,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast:","length":8,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"Pre-register here","length":17,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Dial-In: ","length":8,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"(800) 715-9871 toll-free or (646) 307-1963 for international callers","length":68,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Conference ID:","length":14,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","...